SHEN Taoye, GUO Jianhao, WANG Xiaojuan, JIANG Saiping. Research Progress in the Treatment of Acute Lung Injury[J]. Chinese Journal of Modern Applied Pharmacy, 2021, 38(3): 366-370. DOI: 10.13748/j.cnki.issn1007-7693.2021.03.020
    Citation: SHEN Taoye, GUO Jianhao, WANG Xiaojuan, JIANG Saiping. Research Progress in the Treatment of Acute Lung Injury[J]. Chinese Journal of Modern Applied Pharmacy, 2021, 38(3): 366-370. DOI: 10.13748/j.cnki.issn1007-7693.2021.03.020

    Research Progress in the Treatment of Acute Lung Injury

    • Acute lung injury(ALI) is a common clinical critical illness. Its exacerbation stage is acute respiratory distress syndrome(ARDS). The mortality rate is as high as 30%-50%, which seriously threatens people's life and health. Even if the patients survive, the function of lung is severely impaired, thus severely affecting the quality of the patients' life and causing a large economic burden on the patient, family and society. The complex pathological mechanisms of ALI make its effective treatment still a tremendous challenge clinically. Presently, the treatment strategies of ALI mainly include respiratory support therapy, drug therapy, gene therapy, cell transplantation and other means. A brief review of the research progress of ALI therapy is presented.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return